Literature DB >> 3117170

Migration and gout: the Tokelau Island migrant study.

I A Prior1, T J Welby, T Ostbye, C E Salmond, Y M Stokes.   

Abstract

The prevalence and 14 year incidence of clinical gout and its precursors were investigated in the Polynesian population of Tokelauans living in the Pacific basin, non-migrant Tokelauans living in their isolated atoll homeland being compared with migrant Tokelauans living in urban New Zealand. The age standardised prevalence of gout in Tokelauan men in New Zealand was higher than that in non-migrant Tokelauan men, being 21.0 and 19.5/1000 subjects at the beginning of the study and 51.0 and 14.6/1000 at the end of study, respectively. Migrant men in New Zealand aged under 55 had higher mean serum uric acid concentrations than non-migrant men of the same age. The prevalence of gout was low in women in both environments. The age standardised relative risk of developing gout between 1968 and 1982 was 9.0 times higher in the migrant men than in the non-migrant men. Age, serum uric acid concentration, serum cholesterol concentration, and self reported alcohol consumption at entry to the study were the best set of predictors of gout in men. Preventive strategies to change body mass, diet, and patterns of alcohol use need to be developed in this population.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3117170      PMCID: PMC1247326          DOI: 10.1136/bmj.295.6596.457

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN: 0267-0623


  15 in total

Review 1.  Gout in Maoris.

Authors:  B S Rose
Journal:  Semin Arthritis Rheum       Date:  1975-11       Impact factor: 5.532

2.  METABOLIC MALADIES IN NEW ZEALAND MAORIS.

Authors:  I A PRIOR; B S ROSE; F DAVIDSON
Journal:  Br Med J       Date:  1964-04-25

Review 3.  Hyperuricemia and gout. Classification, complications and management.

Authors:  G R Boss; J E Seegmiller
Journal:  N Engl J Med       Date:  1979-06-28       Impact factor: 91.245

4.  The Tokelau Island migrant study.

Authors:  I A Prior; J M Stanhope; J G Evans; C E Salmond
Journal:  Int J Epidemiol       Date:  1974-09       Impact factor: 7.196

5.  The Tokelau Island Migrant Study: serum lipid concentration in two environments.

Authors:  J M Stanhope; V M Sampson; I A Prior
Journal:  J Chronic Dis       Date:  1981

6.  Hyperuricaemia and gout in Western Samoans.

Authors:  L Jackson; R Taylor; S Faaiuso; S P Ainuu; S Whitehouse; P Zimmet
Journal:  J Chronic Dis       Date:  1981

7.  A prospective study of gout in New Zealand Maoris.

Authors:  G W Brauer; I A Prior
Journal:  Ann Rheum Dis       Date:  1978-10       Impact factor: 19.103

8.  Hyperuricaemia, gout, and diabetic abnormality in Polynesian people.

Authors:  I A Prior; B S Rose; H P Harvey; F Davidson
Journal:  Lancet       Date:  1966-02-12       Impact factor: 79.321

9.  The Tokelau Island migrant study: alcohol consumption in two environments.

Authors:  J M Stanhope; I A Prior
Journal:  N Z Med J       Date:  1979-11-28

10.  High prevalence of hyperuricaemia and gout in an urbanised Micronesian population.

Authors:  P Z Zimmet; S Whitehouse; L Jackson; K Thoma
Journal:  Br Med J       Date:  1978-05-13
View more
  12 in total

Review 1.  Risk factors for gout and prevention: a systematic review of the literature.

Authors:  Jasvinder A Singh; Supriya G Reddy; Joseph Kundukulam
Journal:  Curr Opin Rheumatol       Date:  2011-03       Impact factor: 5.006

Review 2.  Global epidemiology of gout: prevalence, incidence and risk factors.

Authors:  Chang-Fu Kuo; Matthew J Grainge; Weiya Zhang; Michael Doherty
Journal:  Nat Rev Rheumatol       Date:  2015-07-07       Impact factor: 20.543

3.  Population Impact Attributable to Modifiable Risk Factors for Hyperuricemia.

Authors:  Hyon K Choi; Natalie McCormick; Na Lu; Sharan K Rai; Chio Yokose; Yuqing Zhang
Journal:  Arthritis Rheumatol       Date:  2019-12-03       Impact factor: 10.995

4.  Genomewide scan for gout in taiwanese aborigines reveals linkage to chromosome 4q25.

Authors:  Li Shu-Chuan Cheng; Shang-Lun Chiang; Hung-Pin Tu; Shun-Jen Chang; Tsu-Nai Wang; Allen Min-Jen Ko; Ranajit Chakraborty; Ying-Chin Ko
Journal:  Am J Hum Genet       Date:  2004-07-13       Impact factor: 11.025

5.  Rheumatic disease in a Philippine village. II: a WHO-ILAR-APLAR COPCORD study, phases II and III.

Authors:  R Wigley; L Manahan; K D Muirden; R Caragay; B Pinfold; K G Couchman; H A Valkenburg
Journal:  Rheumatol Int       Date:  1991       Impact factor: 2.631

6.  Type 2 (non-insulin-dependent) diabetes mellitus, migration and westernisation: the Tokelau Island Migrant Study.

Authors:  T Ostbye; T J Welby; I A Prior; C E Salmond; Y M Stokes
Journal:  Diabetologia       Date:  1989-08       Impact factor: 10.122

7.  The experience and impact of gout in Māori and Pacific people: a prospective observational study.

Authors:  Nicola Dalbeth; Meaghan E House; Anne Horne; Leanne Te Karu; Keith J Petrie; Fiona M McQueen; William J Taylor
Journal:  Clin Rheumatol       Date:  2012-11-01       Impact factor: 2.980

8.  Racial disparities in the risk of Stevens-Johnson Syndrome and toxic epidermal necrolysis as urate-lowering drug adverse events in the United States.

Authors:  Na Lu; Sharan K Rai; Robert Terkeltaub; Seoyoung C Kim; Mariano E Menendez; Hyon K Choi
Journal:  Semin Arthritis Rheum       Date:  2016-03-31       Impact factor: 5.532

Review 9.  Hyperuricaemia in the Pacific: why the elevated serum urate levels?

Authors:  Anna L Gosling; Elizabeth Matisoo-Smith; Tony R Merriman
Journal:  Rheumatol Int       Date:  2013-12-31       Impact factor: 3.580

Review 10.  Dietary and Lifestyle-Centered Approach in Gout Care and Prevention.

Authors:  Chio Yokose; Natalie McCormick; Hyon K Choi
Journal:  Curr Rheumatol Rep       Date:  2021-07-01       Impact factor: 4.686

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.